Slingshot members are tracking this event:

FDA's Advisory Committee Votes in Favor of Approval of Merck's (MRK) Muscle Relaxant Reversal Agent BRIDION

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 06, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Sugammadex, Bridion, Reversal Agent For Muscle Relaxants, Adcom